TVRD
Tvardi Therapeutics
TVRD
TVRD
135 hedge funds and large institutions have $438M invested in Tvardi Therapeutics in 2019 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 35 increasing their positions, 43 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
1% more funds holding
Funds holding: 134 → 135 (+1)
0.14% less ownership
Funds ownership: 1.71% → 1.57% (-0.14%)
19% less repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 43
Holders
135
Holding in Top 10
3
Calls
$16.3M
Puts
$15.6M
Top Buyers
| 1 | +$5.25M | |
| 2 | +$3.92M | |
| 3 | +$2.84M | |
| 4 |
Parallax Volatility Advisers
San Francisco,
California
|
+$2.39M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.38M |
Top Sellers
| 1 | -$7.62M | |
| 2 | -$7.01M | |
| 3 | -$5.69M | |
| 4 |
Millennium Management
New York
|
-$5.67M |
| 5 |
Renaissance Technologies
New York
|
-$5.37M |